Promoting Atrial Fibrillation Screening in Primary Care

Status Not yet recruiting

Clinical Trial Summary

Atrial fibrillation is the most common sustained cardiac arrhythmia in adults. Due to the asymptomatic and paroxysmal nature (randomly and shortly occurring of atrial fibrillation, and can therefore remain unnoticed) of atrial fibrillation. Atrial fibrillation increases the risk of stroke five fold if left untreated. Screening in old populations above age 65 years is helpful to find more atrial fibrillation cases. However, screening for atrial fibrillation is not well implemented in China. Thus, this project aims to promote atrial fibrillation screening in primary care centers in China. We will develop an intervention program (SEARCH-AF) and examine the effects (including the clinical effects and implementation effects) of program.

Clinical Trial Description

Six health care centers in Guangzhou China will be included. We will adopt a stepped-wedge randomized trial design. Two health care centers will be randomly selected to receive the SEARCH-AF program at each step (a total of three steps). The SEARCH-AF program will include opportunistic screening among those who aged 65 or above and screening promoting strategies. The A total of 4800 old adults will be screened for atrial fibrillation using a handheld single-lead ECG tool upon their visit to family doctor, with 800 for each health care center. The promoting strategy will be developed based on the Consolidated Framework for Implementation Research and include leadership engagement, policy support, providing screening resources, staff training on atrial fibrillation screening and management. The whole study will last for 18 months. We will examine the intervention effects including clinical effects (atrial fibrillation detection rate, anticoagulation rate, atrial fibrillation related hospital visits, and stroke related end points) and implementation effects (cost-effectiveness of the intervention, compliance to atrial fibrillation screening ). ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06458829
Study type	Interventional
Source	Sun Yat-sen University
Contact	Xi CAO, PhD
Phone	(86)02084333829
Email	caox29@mail.sysu.edu.cn
Status	Not yet recruiting
Phase	N/A
Start date	July 1, 2024
Completion date	December 30, 2026

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06055751` - Long Term Evaluation of Cardiac Arrhythmias After Transcatheter Aortic Valve Implantation -The LOCATE Registry
Recruiting	`NCT04870424` - Colchicine for Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement	Phase 3
Completed	`NCT05818592` - Screening for Atrial Fibrillation With Self Pulse Monitoring	N/A
Active, not recruiting	`NCT05780320` - A Pharmaco-surgical Approach to Reduce Postoperative Atrial Fibrillation After Cardiac Surgery
Active, not recruiting	`NCT03866148` - Obstructive Sleep Apnoea and Cardiac Arrhythmias	N/A
Withdrawn	`NCT05656170` - Stellate Ganglion to Prevent Atrial Fibrillation	N/A
Active, not recruiting	`NCT05255224` - PARADISE: Predicting AF After Cardiac Surgery
Recruiting	`NCT04528511` - BurdEn of NEw Onset Atrial FIbrillation in patienTs With Acute Myocardial Infarction
Recruiting	`NCT04857268` - Diagnostic Validation of Wearable ECG Monitoring Patch, ATP-C120	N/A
Completed	`NCT04118270` - Shared Decision-Making: AFib 2gether Mobile App	N/A
Active, not recruiting	`NCT03345615` - Standard Versus Intensive Monitoring After Myocardial Infarction Looking for Atrial Fibrillation	N/A
Not yet recruiting	`NCT05841056` - Short Term Anti-aRrhythmic Therapy for Post-Operative AF in Cardiac Surgery Patients Pilot Trial	Phase 3
Recruiting	`NCT06275503` - STROKESTOP III - Optimized Method for Atrial Fibrillation Screening	N/A
Recruiting	`NCT05149820` - Point of Care RandOmisation Systems for Performing Embedded Comparative Effectiveness Trials Of Routine Treatments	Phase 4
Completed	`NCT03221777` - Atrial Fibrillation Occurring Transiently With Stress (AFOTS)
Not yet recruiting	`NCT03991754` - Prevention of New Onset AF After TAVI (PAF-TAVI Trial)	Phase 3
Completed	`NCT03118518` - STOP AF First: Cryoballoon Catheter Ablation in an Antiarrhythmic Drug Naive Paroxysmal Atrial Fibrillation	N/A
Completed	`NCT03552588` - High Sensitivity Estimate of the Incidence of Atrial Fibrillation Occurring Transiently With Stress (AFOTS Incidence Study)
Recruiting	`NCT05444335` - Screening for Atrial Fibrillation in Elderly Women Older Than 70 Years	N/A
Terminated	`NCT05950971` - Rhythm Control Versus Rate Control for New Onset Atrial Fibrillation	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.